1-Methoxy-5-methylphenazinium methyl sulfate

Suppliers

Names

[ CAS No. ]:
65162-13-2

[ Name ]:
1-Methoxy-5-methylphenazinium methyl sulfate

[Synonym ]:
EINECS 265-579-6
1-Methoxy-5-methylphenazin-5-ium methyl sulfate
1-methoxy-5-methylphenazin-5-ium,methyl sulfate
MFCD00040648
1-METHOXY PMS
Methoxy-PMS

Chemical & Physical Properties

[ Melting Point ]:
172 °C

[ Molecular Formula ]:
C15H16N2O5S

[ Molecular Weight ]:
336.363

[ Exact Mass ]:
336.078003

[ PSA ]:
100.81000

[ LogP ]:
2.39490

MSDS

Safety Information

[ Symbol ]:

GHS07, GHS08

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H319-H351

[ Precautionary Statements ]:
P281-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
R22

[ Safety Phrases ]:
S26

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Precursor

  • 1-METHOXYPHENAZINE
  • Dimethyl sulfate

DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor.

Pain 156 , 1320-33, (2015)

Neuropathic pain is a chronic pain syndrome that arises from nerve injury. Current treatments only offer limited relief, clearly indicating the need for more effective therapeutic strategies. Previous...

Myo5b knockout mice as a model of microvillus inclusion disease.

Sci. Rep. 5 , 12312, (2015)

Inherited MYO5B mutations have recently been associated with microvillus inclusion disease (MVID), an autosomal recessive syndrome characterized by intractable, life-threatening, watery diarrhea appea...

Uptake and bio-reactivity of polystyrene nanoparticles is affected by surface modifications, ageing and LPS adsorption: in vitro studies on neural tissue cells.

Nanoscale 7(9) , 4199-210, (2015)

Because of their capacity of crossing an intact blood-brain barrier and reaching the brain through an injured barrier or via the nasal epithelium, nanoparticles have been considered as vehicles to del...


More Articles


Related Compounds

  • 1-methoxy-5-methyl-hexan-3-one
  • 1-methoxy-5-methyl-6-hepten-2-one
  • 1-methoxy-5-methyl-2-(2-nitroprop-1-enyl)-4-phenylmethoxybenzene
  • 1-methoxy-5-methyl-heptan-3-one
  • 1-METHOXY-5-METHYL-HEX-1-EN-3-ONE
  • 1-methoxy-5-methyl-bicyclo[3.1.0]hexane
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 1'-cyclobutyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[3H-1-benzofuran-2,4'-azepane]
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide